drugset / Trial / NCT02372357
A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area
Phase 4
Completed
14 enrolled
Universitaire Ziekenhuizen KU Leuven
Institutul Clinic Fundeni · collab
NaSingle-groupOpen-labelPrevention
Summary
A new prophylactic posaconazole dosing regimen of 120mg/m² tid is evaluated pharmacologically in children 13 years and younger, suffering from a hematologic malignancy.
Timeline
- Start
- 2012-02
- Primary completion
- 2014-08
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Posaconazole | Small molecule | 120 mg/m2 | Oral |